Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.120
-0.060 (-2.75%)
Nov 20, 2024, 4:00 PM EST - Market closed
Senti Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | 2.56 | 4.29 | 2.76 | 0.57 | 0.09 |
| Revenue Growth (YoY) | - | -40.25% | 55.23% | 387.81% | 565.88% | - |
| Cost of Revenue | 9.12 | 32.15 | 28.15 | 21.96 | 15.96 | 14.52 |
| Gross Profit | -9.12 | -29.59 | -23.86 | -19.2 | -15.39 | -14.44 |
| Selling, General & Admin | 21.15 | 34.85 | 38.23 | 21.25 | 9.3 | 7.34 |
| Operating Expenses | 47.74 | 34.85 | 38.23 | 21.25 | 9.3 | 7.34 |
| Operating Income | -56.86 | -64.44 | -62.08 | -40.45 | -24.69 | -21.78 |
| Interest & Investment Income | 1.14 | 2.86 | 1.7 | 0.01 | 0.09 | 0.67 |
| Other Non Operating Income (Expenses) | 2.33 | 3.3 | -0.03 | -0.12 | -0.05 | -0.04 |
| EBT Excluding Unusual Items | -53.38 | -58.28 | -60.42 | -40.56 | -24.65 | -21.15 |
| Asset Writedown | -0.58 | -25.96 | - | -0.02 | -0.24 | -0.01 |
| Other Unusual Items | -16.9 | 0.83 | 10.75 | -14.74 | 5.03 | - |
| Pretax Income | -70.87 | -83.41 | -49.67 | -55.32 | -19.86 | -21.16 |
| Earnings From Continuing Operations | -70.87 | -83.41 | -49.67 | -55.32 | -19.86 | -21.16 |
| Earnings From Discontinued Operations | -0.03 | 12.35 | -8.55 | - | - | - |
| Net Income | -70.9 | -71.06 | -58.21 | -55.32 | -19.86 | -21.16 |
| Net Income to Common | -70.9 | -71.06 | -58.21 | -55.32 | -19.86 | -21.16 |
| Shares Outstanding (Basic) | 5 | 4 | 3 | 0 | 1 | 1 |
| Shares Outstanding (Diluted) | 5 | 4 | 3 | 0 | 1 | 1 |
| Shares Change (YoY) | 2.86% | 69.94% | 796.58% | -78.99% | 2.03% | - |
| EPS (Basic) | -15.59 | -16.01 | -22.29 | -189.95 | -14.33 | -15.57 |
| EPS (Diluted) | -15.59 | -16.01 | -22.29 | -189.95 | -14.33 | -15.57 |
| Free Cash Flow | -34.95 | -64.43 | -76.27 | -40.18 | -25.33 | -20.37 |
| Free Cash Flow Per Share | -7.69 | -14.52 | -29.21 | -137.96 | -18.28 | -15.00 |
| Operating Margin | - | -2516.28% | -1448.53% | -1464.90% | -4362.90% | -25625.88% |
| Profit Margin | - | -2774.62% | -1358.14% | -2003.59% | -3509.19% | -24890.59% |
| Free Cash Flow Margin | - | -2515.93% | -1779.51% | -1455.20% | -4475.97% | -23969.41% |
| EBITDA | -52.96 | -60.88 | -60.69 | -39.68 | -24.13 | -21.36 |
| D&A For EBITDA | 3.89 | 3.56 | 1.4 | 0.77 | 0.56 | 0.43 |
| EBIT | -56.86 | -64.44 | -62.08 | -40.45 | -24.69 | -21.78 |
| Revenue as Reported | - | 2.56 | 4.29 | 2.76 | 0.57 | 0.09 |
Source: S&P Capital IQ. Standard template.
Financial Sources.